These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. Ozen ME; Yumru M; Savas HA; Cansel N; Herken H World J Biol Psychiatry; 2007; 8(1):42-4. PubMed ID: 17366349 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome: a case report. Fekadu A; Wakwoya A Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317 [TBL] [Abstract][Full Text] [Related]
11. Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Joshi PT; Capozzoli JA; Coyle JT Pediatrics; 1991 Feb; 87(2):235-9. PubMed ID: 1670966 [TBL] [Abstract][Full Text] [Related]
12. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S; Kornreich C; Choubani Z; Gourevitch R Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [TBL] [Abstract][Full Text] [Related]
13. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review. Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319 [TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome. Musselman ME; Browning LA; Parker D; Saely S Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic malignant syndrome related to use of clozapine. Trayer JS; Fidler DC J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834 [TBL] [Abstract][Full Text] [Related]
16. NMS after clozapine initiation. Skarpathiotakis M; Westreich N J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854 [No Abstract] [Full Text] [Related]
17. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693 [TBL] [Abstract][Full Text] [Related]
18. Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient. Shim G; Kang DH; Kwon JS J Korean Med Sci; 2008 Aug; 23(4):734-6. PubMed ID: 18756068 [TBL] [Abstract][Full Text] [Related]
19. Neuroleptic toxicity syndromes: a clinical spectrum. Reilly JJ; Crowe SF; Lloyd JH Aust N Z J Psychiatry; 1991 Dec; 25(4):499-505. PubMed ID: 1686547 [TBL] [Abstract][Full Text] [Related]
20. [The application of electroconvulsive therapy in neuroleptic malignant syndrome treatment in patient with catatonic schizophrenia]. Kucia K; Warchala A Wiad Lek; 2005; 58(9-10):572-4. PubMed ID: 16529073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]